Professor George Baillie

Professor George Baillie. 'EASYGEN - Clinical validation of biomarkers for diagnosis, monitoring disease progression and treatment response', European Commission (EC), £325,970.99

Professor George Baillie. 'Enhancing PDE4D7 activity as a novel treatment strategy for prostate cancer', Philips (NL), £4,739

Image of Christian Delles300pxImage of Lorraine Work

Professor Christian Delles, Professor Jesse Dawson, Dr Lorraine Work. 'Seedcorn Funding for Multidisciplinary Stroke Research', The R S Macdonald Charitable Trust, £80,000

300px

Professor Terry Quinn. 'Brain Health ARC data work'. The R S Macdonald Charitable Trust, £79,902

Professor Terry Quinn. 'Stroke researchER to support NHS Research Scotland portfolio studies'. Scottish Stroke Research Network (SRN), £26,000

300px

Professor Will Fuller. 'NCX1 inhibitors for the treatment of heart failure'. Bristol-Myers Squibb (BMS) (US), £70,826

Professor Will Fuller. 'Targeted Degradation of Phospholamban as a Therapeutic Approach for Heart Failure'. Novo Nordisk (DK), £41,000

Professor Will Fuller. 'NCX1 inhibitors for the treatment of heart failure - Evotec Part'. Evotec SE, £7,870

300px

Professor Jesse Dawson. 'Stroke Research Network studies'. Scottish Stroke Research Network (SRN), £56,000.03

 700x450 profile

Dr Alan Cameron, Dr Sam Neilson. 'Innovating AF Screening after Transient Ischaemic Attack: Point-of-Care NT-proBNP and Wearable ECG Patches'. NHS Greater Glasgow and Clyde Endowment Funds, £24,985

Dr Jodi Watt. 'Repurposing of inflammation-related drugs in dementia'. Scottish Neurological Research Fund, £15,816.33

Dr Pierpaolo Pellicori. 'Diurnal Variation in Iron Status in patients with Heart Failure'. The Carnegie Trust for the Universities of Scotland, £14,805

 Image of Robert Sykes

Dr Robert Sykes. 'Functional and structural brain abnormalities in Takotsubo syndrome'. NHS Greater Glasgow and Clyde Endowment Funds, £14,375

new

Professor Patrick Mark. 'Utility of Cardiovascular Biomarkers to Predict Patient Outcomes in Kidney Transplantation'. Office of the Chief Scientific Adviser, £6,028.60


First published: 3 March 2020

<< News